Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Anti-inflammatory agent bindarit reduces MCP-1 excretion in patients with active lupus nephritis

July 28, 2009

Plethora enters evaluation and option agreement for PSD-503

July 20, 2009

Cytochroma initiates pharmacokinetic study of CTAP-101 in stage 3 or 4 CKD patients

July 17, 2009

Rituximab efficacy largely transient in pediatric steroid-dependent nephrotic syndrome

July 14, 2009

Tamsulosin associated with postoperative cataract surgery complications

July 14, 2009

Takeda describes tachykinin receptor antagonists

July 10, 2009

Vasopressin V1b receptor ligands under development at Abbott

July 3, 2009

Vantia reports results from phase IIa clinical trial of VA-106483 in nocturia

July 1, 2009

AEterna Zentaris presents update on phase III study 041 of cetrorelix pamoate in BPH

June 19, 2009

FibroGen starts enrollment in phase II FG-3019 study in diabetic kidney disease

June 17, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...